Discontinuation report MAR-GALANTAMINE ER
| Report ID | 148100 |
| Drug Identification Number | 02420821 |
| Brand name | MAR-GALANTAMINE ER |
| Common or Proper name | Galantamine |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | GALANTAMINE |
| Strength(s) | 8MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2017-04-01 |
| Remaining supply date | 2017-04-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2021-10-26 | French | Compare |
| v1 | 2021-10-26 | English | Compare |
Showing 1 to 2 of 2